AURINIA PHARMACEUTICALS INC (AUPH)
CA05156V1022 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -62.56M | -78.02M | -108.18M | -180.97M | -102.68M | |||
| Depreciation Amortization | 15.87M | 11.65M | 2.71M | 2.76M | 1.37M | |||
| Change In Working Capital | -3.12M | -5.61M | -6.82M | -21.63M | 4.52M | |||
| Taxes Paid | 496.00K | 496.00K | -1.98M | -260.00K | N/A | |||
| Other non cash items | 29.41M | 38.52M | 32.76M | 42.15M | 26.93M | |||
| OPERATING CASH FLOW | -20.39M | -33.46M | -79.53M | -157.69M | -69.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -220.00K | -718.00K | -290.00K | -1.50M | -7.34M | |||
| Other Investing Activity | 17.89M | -5.99M | -60.34M | -102.37M | -150.84M | |||
| INVESTING CASH FLOW | 17.67M | -6.71M | -60.63M | -103.87M | -158.19M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -10.03M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 3.28M | 4.89M | 2.43M | 221.11M | 194.38M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -21.82M | -5.13M | 2.43M | 221.11M | 194.38M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -24.54M | -45.30M | -137.73M | -40.45M | -33.67M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -20.39M | -33.46M | -79.53M | -157.69M | -69.86M | |||
| Capital Expenditure | -220.00K | -718.00K | -290.00K | -1.50M | -7.34M | |||
| FREE CASH FLOW | -20.61M | -34.18M | -79.82M | -159.19M | -77.20M | |||
All data in USD